Summit Partners Public Asset Management, LLC Procept Bio Robotics Corp Transaction History
Summit Partners Public Asset Management, LLC
- $3.3 Billion
- Q1 2025
A detailed history of Summit Partners Public Asset Management, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Summit Partners Public Asset Management, LLC holds 410,292 shares of PRCT stock, worth $15.8 Million. This represents 0.73% of its overall portfolio holdings.
Number of Shares
410,292
Previous 551,767
25.64%
Holding current value
$15.8 Million
Previous $44.4 Million
46.2%
% of portfolio
0.73%
Previous 1.08%
Shares
6 transactions
Others Institutions Holding PRCT
# of Institutions
303Shares Held
43.5MCall Options Held
286KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.13MShares$197 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$134 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.14MShares$82.3 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.42MShares$54.4 Million0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA1.3MShares$49.9 Million0.01% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.71B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...